Dianthus Therapeutics | MGTA - Ebit





Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Avita Medical AUD -10.39M 1.72M 2025-12
Celltrion KRW 13.41B 1.33B 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Moderna USD -815M 573M 2026-06
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 291M 33M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR -1.4M 2.03M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 73.7M 93.9M 2026-06
Xeris Pharmaceuticals USD 9.12M 7.65M 2026-03
Zealand Pharma A/S -389M 318.05M 2026-03
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03